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Abstract
The key role of cell cultures in different scientific fields is worldwide recognized, both as in
vitro research models alternative to laboratory animals and substrates for biological produc-
tion. However, many safety concerns rise from the use of animal/human cell lines that may
be tumorigenic, leading to potential adverse contaminations in cell-derived biologicals.
In order to evaluate the suitability of 13 different cell lines for Poliovirus vaccine produc-
tion, safety and quality, in vitro/in vivo tumorigenicity and Poliovirus propagation properties
were evaluated.
Our results revealed that non-human primate cell lines CYNOM-K1, FRhK-4, 4MBr-5
and 4647 are free of tumorigenic features and represent highly susceptible substrates for
attenuated Sabin Poliovirus strains. In particular, FRhK-4 and 4647 cell lines are character-
ized by a higher in vitro replication, resulting indicated for the use in large-scale production
field.
Introduction
Poliomyelitis is a highly contagious disease caused by a virus of the Enterovirus genus, belong-
ing to the Picornaviridae family, known as Poliovirus and composed by a 7,500 nucleotides (+)
single stranded RNA molecule [1,2]. Three different serotypes of wild Poliovirus were identi-
fied and classified as type 1, type 2 and type 3 [3]. No specific therapy is available against the
virus, but effective inactivated and attenuated vaccines are essential to prevent the disease.
Since the development of the first vaccines by Salk in 1955 and Sabin in 1960 [4,5], Poliovirus
study greatly improved, taking advantage of cell cultures to isolate the virus from infected peo-
ple [6,7], microcarrier technology [8,9] and simian cell lines for large-scale production of
infected cells for vaccine manufacture [10–14].
Immortalization of animal and human cells, derived from primary cell cultures, is a phe-
nomenon mainly due to genetic mutations or infections by oncogenic viruses, which can result
in the appearance of transformed features and tumorigenic properties. Furthermore, cells can
undergo several modifications during in vitro cultivation, resulting in the appearance of novel
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biochemical, biological and genetic characteristics that differ from primary or diploid cell
ones. This represents an important issue in order to establish the biosafety of the cell lines used
as substrates and to monitor the possible transmission of animal pathogens to human recipi-
ents [15].
Among continuous cell lines, the human HeLa cell line, naturally contaminated by human
Papillomavirus, revolutionized the study of Poliovirus biology. On the other hand, Vero cells,
widely used in Poliovirus vaccine manufacturing, became immortalized through a spontane-
ous, unknown process and they acquired tumorigenic properties with increasing in vitro pas-
sage levels [16–18]. Moreover, recent studies have demonstrated that the in vitro establishment
of two African green monkey kidney derived cell lines, named BS-C-1 and CV-1, gave rise to
transformed colonies and tumor formation in the rat model [18–20].
The aim of this research was to identify cell lines free of any transformation ability and
tumorigenicity, suitable for Poliovirus vaccine production. In this respect, thirteen simian cell
lines have been screened in vitro and in vivo for transformation and tumorigenicity features
and their permissiveness to Poliovirus infection investigated, in comparison with other well-
established substrates.
Materials and Methods
Cell lines
All the investigated simian cell lines reported in Table 1 were stored at the Italian Biobank of
Veterinary Resources of IZSLER, the OIE Collaborating Centre for Veterinary Biological Bio-
bank (Brescia, Italy; www.ibvr.org) and are available upon request. All these are continuous,
spontaneously immortalized cell lines, exception made for CYNOM-K1, CV-1 (finite cell
lines) and 4MBr-5 (EFG-dependent line). The investigations were performed at the passages
indicated.
Moreover, seven cell lines used as controls or as substrates are reported in a separate section
of Table 1. MRC-5, LLC-MK2 and RK13.6 were used as substrates in adventitious agents
investigation, while HEp2 and 3T3BALB/c as positive and negative controls in tumorigenicity
assays. LCP were infected with Maedi-Visna virus (VIR RE RSCIC 312) and used as retrovirus
positive sample.
Furthermore, MRC-5 and LLC-MK2 cell lines were selected to prepare “master” batches of
three types of Poliovirus (see Poliovirus propagation section).
Cells were cryopreserved in vapor phase nitrogen until use. After thawing at 37˚C, they
were diluted in MEM culture medium (Sigma-Aldrich, Milan, Italy), free of antibiotics, sup-
plemented with 4mM L-glutamine (Sigma-Aldrich) and centrifuged at 125 g for 5 minutes at
20˚C, in order to remove the dimethyl sulfoxide cryoprotectant agent. Cells were stained with
Trypan Blue (Sigma-Aldrich), counted and checked for viability by a Cellometer1 Automated
Cell Counter (Nexcelom Bioscience, USA). Finally, 1x105 viable cells of each cell line were
seeded in a 75 cm2-flask and incubated at 37˚C in 5% CO2 in the below reported culture
media, enriched with 10% (v/v) of Fetal Bovine Serum (FBS; Euroclone, Milan, Italy).
BGMK, BS-C-1, CYNOM-K1, HeLa, HEp2, LCP, LLC-MK2, MA-104, MARC-145, RK13.6
and Vero cell lines were amplified in MEM, while FRhK-4, FrP3, RC 37 and 4647 cell lines in
D-MEM (Sigma-Aldrich). NCTC cl 3526 cell line was maintained in NCTC 135 medium
(Thermo Fisher Scientific) and CV-1 in Eagle’s basal medium in Hanks’ BSS with amino acids
and vitamins (Sigma-Aldrich). 4MBr-5 were propagated in Ham’s F K12 medium(Thermo
Fisher Scientific) with 2 mM L-glutamine, adjusted to contain 1.5 g/L sodium bicarbonate and
supplemented with 30 ng/ml epidermal growth factor, while 3T3BALB/c and MRC-5 cells
were grown in MEM supplemented with 1 mM sodium pyruvate (Sigma-Aldrich).
Poliovirus Replication in Simian Cell Lines
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Microbiological testing
All cell lines were tested for bacteria, fungi and yeast contamination. Each cell suspension was
inoculated in Agar Sabouraud, Triptic Soy Agar and Brain Heart Infusion microbiological
media (Sigma-Aldrich). The mixtures were incubated for 5 days at 30˚C and for 3 days at
37˚C, respectively, and observed daily in order to detect any contamination. Mycoplasma
infection was evaluated using the commercial MycoSensor PCR Assay Kit (M-Medical S.r.l.,
Milan, Italy) according to the manufacturer’s instructions.
Virology assays
Virus contamination of each cell line was investigated by Real-Time PCR assay. HCMV
(Human Cytomegalovirus), HIV (Human Immunodeficiency Virus), HSV-1 (Herpes Simplex
Virus1), HSV-2 (Herpes Simplex Virus2), EBV (Epstein-Barr Virus), HBV (Hepatitis B Virus)
and HCV (Hepatitis C Virus) were examined by artus1 RG PCR Kit (Qiagen, Milan, Italy),
according to the manufacturer’s instructions. HHV-6 (Human Herpesvirus 6), HHV-7
(Human Herpesvirus 7), HHV-8 (Human Herpesvirus 8) and HPV (Human Papilloma Virus)
Table 1. Cell lines used in the study.
Cell line Species and Tissue Origin Original source and catalogue
number
IZSLER Biobank
code
Passage
Tested cell lines BGMK Buffalo Green Monkey Kidney Flow Laboratories BS CL 07 95
BS-C-1 African Green Monkey Kidney ATCC˚ CCL-26 BS CL 09 66
CYNOM-K1 Monkey Cynomolgus Skin ECACCˆ 90071809 BS CL 221 25
CV-1 African Green Monkey Kidney ATCC CCL-70 BS CL 23 45
FRhK-4 Fetal RhesusMonkey Kidney ATCC CRL-1688 BS CL 115 78
FrP3 Fetal Rhesus Monkey Kidney ISS* BS CL 169 32
LLC-MK2 Rhesus MonkeyKidney ATCC CCL-7 BS CL 57 37
MA-104 Fetal Monkey Kidney University of Perugia, Italy BS CL 61 33
MARC-145 Fetal Monkey Kidney MARC• BS CL 127 25
NCTC cl
3526
Rhesus Monkey Kidney ATCC CCL-7.2 [derivative of
LLC-MK2]
BS CL 70 283
RC 37 Monkey Kidney University of Parma BS CL 189 13
4647 Monkey Vervet Kidney ECACC 90091902 BS CL 223 11
4MBr-5 Macaca Mulatta Monkey Lung ATCC CCL-208 BS CL 222 31
Control or substrate cell
lines
HeLa Human cervix epitheloid
carcinoma
ATCC CCL-2 BS CL 20 105
HEp-2 Human larinx epidermoid
carcinoma
ATCC CCL-23 BS TCL 23 363
LCP Lamb Choroid Plexus Reparto substrati cellulari, IZSLER BS PRC 21 -
MRC-5 Embryonic human lung ATCC CCL-171 BS CL 68 20
RK13.6 Rabbit Kidney Labtek˜ BS CL 196 76
Vero African green monkey kidney ATCC CCL-81 BS CL 86 124
3T3BALB/c Mouse fibroblast ATCC CCL-6587 BS CL 82 116
˚American Type Culture Collection, USA;
ˆEuropean Collection of Authenticated Cell Cultures, UK;
*IstitutoSuperiore di Sanità, Italy;
•Meat Animal Research Center, USA;
˜Labtek, Corsico, Milano (I).
doi:10.1371/journal.pone.0169391.t001
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were evaluated by a Real Quality PCR kit (AB AnaliticaSrl, Padova, Italy), following the manu-
facturer’s instructions. Finally, Influenza virus type A was examined using the primers M-for
(5’-AGATGAGTCTTCTAACCGAGGTCG-3’), M-rev (5’-TGCAAAAACATCTTCAAGTCTCT
G-3’) proposed by van de Brand and colleagues [21], the probe INF-M (5’-TET-TCAGGCC
CCCTCAAAGCCGA-BHQ1-3’, [22]) and the QuantiTect Virus kit (Qiagen), according to the
manufacturer’s instructions. Positive and negative controls, provided by the manufacturer,
have been included in each session.
In vitro testing for adventitious agents was performed in compliance with the European
Pharmacopoeia recommendations (Cell substrates for the production of vaccines for human
use) [23]. Cell culture samples and cell cryolisates were investigated on MRC-5, RK13.6 and
LCC-MK2 cells grown in 24-well plates for adventitious viruses with the ability to induce
cytopathic effect (CPE) (co-culture and cryolisate method). Briefly, 0.1 ml of each sample
was inoculated on cell monolayers and, following adsorption for 30 minutes, cells were fed
with the specific growth medium containing 3% (v/v) of FBS and incubated at 37˚C in 5%
CO2. After 7 days of growth, medium was renewed, while monolayers were observed daily
for CPE for 14 days. On day 14, treated LCC-MK2 cells were removed from the incubator
and tested for haemadsorption of guinea pig and chicken erythrocytes. Briefly, cell monolay-
ers were washed and duplicate wells were overlaid with 0.5 ml of 0.5% (v/v) of guinea pig
and chicken erythrocytes and, after 30 minutes of incubation at room temperature, exam-
ined for adsorption. As positive control H/A/WSN/33 (VIR RE RSCIC 50) influenza virus
was used.
Cell cultures were also examined for the presence of retroviruses, using the Reverse Tran-
scriptase Assay, colorimetric kit (ROCHE, Basel, Switzerland) for the quantitative determina-
tion of the viral Reverse Transcriptase (RT) activity. According to manufacturer’s instructions,
a calibration curve was prepared from HIV-1 RT included in the kit. For the lysis of the retro-
viruses, 40 μl of supernatant were mixed with 40 μl of Lysis Buffer. After 30 minutes of incuba-
tion at room temperature, 20 μl of the reaction mixture were added to each reaction and HIV-
1 RT standard tube. Finally, samples were incubated at 37˚C for 15 h. Samples and HIV-1 RT
dilutions were transferred into the wells of the MP modules and incubated for 1 h at 37˚C. The
solution was completely removed and the strip was rinsed 5 times with 250 μl of Washing
Buffer per well for 30 s. 200 μl of anti-DIG-POD working solution were added and incubated
for 1 h at 37˚C. The solution was completely removed and the washing steps were repeated.
Finally, 200 μl of ABTS Substrate Solution were added and the plate was incubated at room
temperature for 30 minutes. The absorbance was measured at 405 nm by using a Gen5 micro-
plate reader (Biotek, Milan, Italy) and the effective RT activity was extrapolated from the stan-
dard curve.
Species of origin
Species of origin for the considered cell lines was evaluated by isoenzyme analysis, using the
Authentikit System (Innovative Chemistry, Marshfield, USA), according to the manufacturers
protocol. Briefly, cells were submitted to the extraction process by dilution of cell pellet in a
specific buffer included in the kit. The enzyme activity was quantified by addition, after serial
steps, of the Quench-A-Zyme Reagent by spectrophotometer (BioTek). The profiles of glu-
cose-6-phosphatedehydrogenase, lactate dehydrogenase, nucleoside phosphorylase, malate
dehydrogenase, mannose phosphate isomerase peptidase B, and aspartate aminotransferase
isoenzymes were evaluated by electrophoresis. Species of origin was determined by comparing
the migration distance of the analyzed isoenzyme systems with the reference distances pro-
vided by the kit [24].
Poliovirus Replication in Simian Cell Lines
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In vitro transformation assay
All the selected cell lines were tested for tumorigenicity according to the European Pharmaco-
poeia [23]. Soft agar colony assay was performed as previously described [25]. Briefly, 1% agar
noble (Becton Dickinson, NJ, USA) was mixed with 50% of 2X MEM free of antibiotics, sup-
plemented with 20% FBS and stratified into 6-well plates (3 ml/well). After solidification at
room temperature for 1 h, this layer was overlaid with 0.8 ml of 1x105cells/well suspension
diluted in a mixture composed by 50% MEM supplemented by 20% FBS, and 50% of 0.6%
agar noble. Plates were incubated at 20˚C to allow solidification and then maintained at 37˚C
in 5% CO2 for 4 weeks and inspected daily by optical microscopy. Samples were considered
negative if no cell growth was observed in soft agar, while the presence of one or more multi-
cellular aggregates was accounted as transformation evidence. HEp2 and 3T3BALB/c cells
were used, respectively, as positive and negative control.
Tumorigenic evaluation
Potential tumorigenic evolution of the cell line that resulted to be negative in soft agar assays
was evaluated by in vivo (Nu/Nu mice) assay, according to the European Pharmacopoeia [23].
The experiment was approved by the ethic committee of IZSLER and performed in compli-
ance with ethical standards, according to the Directive 2010/63/EU on the protection of ani-
mals used for scientific purposes. Positive (HEp2 cells) and negative (3T3BALB/c) controls
were included. All cell culture systems were tested at the same time and this approach allowed
us to use only one positive and negative control, respectively. This strategy was applied in
order to reduce the number of mice included in the in vivo assay, according to 3Rs principles.
For the same reason, the in vivo test was not performed on BS-C-1and CV-1 cell lines because
literature data has already reported their capacity to induce tumors in laboratory animals [18,
20]. Finally, no cell lines that induced transformed colonies in soft agar medium were included
in the in vivo assay.
For the test, 70 athymic, 30-day-old male mice (Nu/Nu genotype), received from Harlan
Laboratories, were used. They were subdivided in seven groups of 10 mice each. Five groups
were inoculated with FRhK-4, MA-104, CYNOM-K1, 4647 and 4MBr-5 cell lines; one group
was injected with the HEp2 cell line (positive control) and, finally, a further group was inocu-
lated with the 3T3BALB/c cell line (negative control). All animal experiments were conducted
at IZSLER, Brescia. The animals were housed on sterile bedding and with water and feed ad
libitum. Each group was injected subcutaneously with 0.2 ml of 107 cell suspension of each cell
line. Five mice from each group were sacrificed 20 days after the injection, while the others
were observed daily for 12 weeks. At the end of the observation period, the animals were
humanely euthanized (CO2 inhalation). A necropsy was carried out on each mouse with the
aim of detecting tumors at the injection site and in other organs (regional lymph nodes, lung,
brain, spleen, kidney and liver). The local area of injection, together with the organs, were col-
lected for histological examination and stained by haematoxylin-eosin, as described by Ferrari
et al. [26]. In the event of tumor formation, animals were euthanized before the end of the
observation period, in order to avoid any needless pain. The test was to be considered invalid
if fewer than 9 of the 10 animals injected with the HEp2 cells, used as the positive control, did
not show progressively growing tumors.
Poliovirus propagation
The Poliovirus attenuated strains LsC 2ab Sabin type 1 (VIR RE RSCIC 48), P712 Ch 2ab Sabin
type 2 (VIR RE RSCIC 182) and Leon 12alb Sabin type 3 (VIR RE RSCIC 183) were gently pro-
vided by Dr. Medici (University of Parma). LsC 2ab Sabin type 1 was cultivated in MRC-5
Poliovirus Replication in Simian Cell Lines
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cells, while P712 Ch 2ab Sabin type 2 and Leon 12alb Sabin type 3 in LLC-MK2. The viruses
were inoculated in the selected cell line seeded in a 75 cm2 flask at 1 MOI with 0.5 ml of culture
medium. Infected cells were incubated at 37˚C in 5% CO2 for 60 minutes and then added to
20 ml of culture medium supplemented by 3% (v/v) FBS; finally, samples were incubated at
37˚C in 5% CO2 for five days. Cultures were observed daily in order to detect CPE and frozen
at -80˚C when CPE reached 80%. Subsequently they were thawed at room temperature, centri-
fuged at 1,000 g for 30 minutes at 4˚C, distributed in aliquots, and stored at -80˚C. The infec-
tious titers were calculated by the Reed and Mu¨ench method [27]. The infectious titres of
Poliovirus batches were the following: Poliovirus LsC 2ab Sabin type 1: 106.24 TCID50/ml; Polio-
virus P712 Ch 2ab Sabin type 2: 107.24 TCID50/ml; Poliovirus Leon 12alb Sabin type 3: 107.74
TCID50/ml.
Replication of poliovirus types
FRhK-4, CYNOM-K1, 4MBr-5 and 4647 cell lines resulted to be devoid of transformation/
tumorigenic evolution and were investigated for permissiveness to Poliovirus. To do this,
4x104 viable cells/cm2 were seeded in 25 cm2 flasks, incubated in MEM added to 10% (v/v) of
FBS at 37˚C in 5% CO2. At 80% confluence, cells were infected at 0.1 MOI. At 80% CPE, flasks
were frozen at -80˚C, thawed, centrifuged at 1,540 g for 20 minutes at 4˚C and supernatant
was distributed into aliquots and used to evaluate the infectious titre, according to Reed and
Mu¨ench formula [27].
For virus titration, each cell line was seeded in 96-well plastic plates and incubated at 37˚C
in 5% CO2 for 24 hours. The virus suspensions, collected from the different cell cultures, were
diluted from 10−1 to 10−8 in culture medium and each dilution was inoculated into the corre-
sponding cell line. Five wells were inoculated with each dilution at a volume of 100 μl/ well.
Control cells were added with culture medium. The plates were incubated at 37˚C, 5% CO2 for
60 minutes and then each plate was added to 100 μl/well of culture medium supplemented by
3% (v/v) FBS and incubated at 37˚C, 5% CO2 for 7 days. Cell cultures were checked daily for
CPE and the infectious titers were evaluated at the end of the observation period. In parallel
sessions, Poliovirus infection has been performed on Vero and HeLa cells, as reference lines
for the production of Poliovirus, and the obtained infectious titers were compared. These tests
were performed in triplicate and the mean infectious titers were calculated.
Statistical analysis
Differences between datasets of Poliovirus infectious titers were checked by one-way ANOVA,
followed by a Dunn’s post-hoc test for multiple comparisons. The significance threshold was
set at P<0.05 (Prism 5, GraphPad Software).
Results
Microbiological testing and virology assays
The cell lines tested proved to be free of microbial and mycoplasma contamination. No virus,
including adventitious agents and retroviruses, has been detected in the selected cell lines.
Results are reported in Table 2.
Species of origin
The isoenzyme test confirmed the monkey origin of all cell lines selected for the study, whereas
the MRC-5 proved to be of human derivation as expected. No cross-contamination was
detected.
Poliovirus Replication in Simian Cell Lines
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In vitro transformation assay
Cell lines reported in the higher section of Table 1 were investigated for their in vitro transfor-
mation ability. The results of the investigation showed that BGMK, FrP3, LLC-MK2, MARC-
145, NCTC cl 3526 and RC 37cell lines induced transformed colonies in soft agar medium.
These colonies began to appear at about 7 days after seeding (Fig 1) and then they increased
gradually in number and size. This behavior was similar to that observed for the HEp2 cell
line, used as positive control. In contrast, no transformed colonies were observed for the nega-
tive control 3T3BALB/c cell line, as well as BS-C-1, CYNOM-K1, CV-1, FRhK-4, 4647, and
4MBr-5 cell lines. All these samples remained negative until the end of the experiment (day
30). Results obtained from MA-104 cells were not clear, since cellular aggregates were detected,
but their features were different from those observed in positive samples (Fig 1).
Tumorigenic evaluation and histology
Cell lines that did not display transformed colonies in vitro were applied for further investiga-
tions to test in vivo tumorigenic properties. The mice injected with CYNOM-K1, FRhK-4,
4647 and 4MBr-5 cell lines did not develop any tumor formation during the observation
period. The same finding was observed for the mice inoculated with the 3T3BALB/c cell line
(negative control; a representative capture is reported in Fig 2A). The group injected with the
positive control (HEp2) developed a hyperplastic tumor at the inoculation area, as expected. In
particular, nodules were already observed about 10 days after the injection and gradually
increased in size (Fig 2B). They appeared smooth, uniform and globular (10 mm Ø); later they
developed a multi-globular shape and increased in size (20 mm Ø). At necropsy, a tumour was
detected only at the cell injection site of the skin; no other macroscopic alterations in the other
organs and tissues were detected.
At the two necropsy times (20 days and 12 weeks after the injection) no tumors were
detected in skin of the inoculum area, lymph nodes, lungs, brain, spleen, kidneys and liver of
the mice injected either with the selected cell lines under investigation or with the 3T3BALB/c
cell line.
Table 2. Cell line quality and tumorigenicity parameters.
Cell line Bacterial and mycoplasma contamination Viral contamination In vitro tranformation ability In vivo tumorigenicity
BGMK - - + nd
BS-C-1 - - - +˚
CYNOM-K1 - - - -
CV-1 - - - +˚
FRhK-4 - - - -
FrP3 - - + nd
LLC-MK2 - - + nd
MA-104 - - dubious -
MARC-145 - - + nd
NCTC cl 3526 - - + nd
RC 37 - - + nd
4647 - - - -
4MBr-5 - - - -
nd: not done; + and - symbols indicate presence and absence of contaminating agents or transformation/tumorigenic ability;
˚ reported by Furesz et al. [18] and Johnson et al.[20]
doi:10.1371/journal.pone.0169391.t002
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The histology carried out on tissue samples taken from mice injected with HEp2 cells
showed the presence of polygonal cells in subcutaneous and dermal tissues; the nuclei of such
cells were irregular in shape, with evident nucleoli (atypical mitosis); moreover, neoplastic
cells were observed in the vessels. These alterations were restricted to the inoculum site. The
tissues and organs of the animals injected with either CYNOM-K1, FRhK-4, 4MBr-5, 4647 cell
lines, or those treated with the negative control 3T3BALB/c cells, did not show any inflamma-
tory process (Fig 2C). In fact the injected cells were completely re-absorbed within a few days
(in mean seven days).
Concerning MA-104 cells, the presence of a foreign body granuloma was detected at the
injection inoculum site (data not shown). The results of the in vitro and in vivo tests are sum-
marized in Table 2.
Replication of poliovirus types
All Poliovirus types replicated in all the investigated cell lines, as well as in Vero and HeLa
cells, tested simultaneously as reference substrates for Poliovirus propagation and vaccine
Fig 1. Soft agar colony assay results. Representative captures of in vitro transformation assay results are reported for each investigated cell line.
doi:10.1371/journal.pone.0169391.g001
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manufacturing. The infectious titers obtained in different assayed cells relative to attenu-
ated Sabin strains type 1, 2 and 3, are reported in Fig 3 in Panel A, B and C, respectively.
TCDI50/ml data are reported as log10 mean ± standard error of the mean and analysed as
indicated in material and methods section. Concerning LsC 2ab Sabin type 1 and P712 Ch
2ab Sabin type 2, TCID50/ml infectious titers ranged between 10
7.24 and 108.16, while Leon
12alb Sabin type 3 between 103.83 and 108.50. They replicated into cells without showing any
dissimilarity between the different substrates, exception made for the observed tendency of
all investigated cell lines in being more permissive to Poliovirus Leon 12alb Sabin type 3
propagation than HeLa and Vero. In particular, FRhK-4 cells showed to be significantly
more sensitive to Leon 12alb Sabin type 3, compared with the simian reference cell line
Vero (TCID50/ml mean: 10
8.50 versus 103.83).
Fig 2. Tumorigenic evaluation and histology. Representative captures of the absence (A) and presence (B) of a nodular lesion, localized
at the site of injection of cells, in treated nude mice. In Panel C histological sections derived from cell-treated mice are reported.
doi:10.1371/journal.pone.0169391.g002
Poliovirus Replication in Simian Cell Lines
PLOS ONE | DOI:10.1371/journal.pone.0169391 January 3, 2017 9 / 13
Discussion
Cell cultures are widely used as substrates for the production of many biotechnological and
biological products for human use, such as viral vaccines. Since the use of biological material
may lead to potential contamination with known and unknown extraneous agents, cell sub-
strates must be properly tested in order to avoid adverse features in patients. In this respect,
the guidelines provided by the International Regulatory Agencies (European Medicines
Agency, European Pharmacopeia, U.S. Food and drug Administration, World Health Organi-
sation) [23, 28–30] require cell line free of any adventitious agents, eubacteria and cross-con-
taminants. In particular, continuous cell lines may represent a risk for the recipients of the
biologicals, since they may vehicle oncogenic and viral components derived from the immor-
talization event (serial subcultivation of a primary cell culture of a human or animal tumor,
transformation by oncogenic viruses, in vitro spontaneous transformation). For these reasons,
cell cultivation history has to be clearly reported and transformation and tumorigenicity prop-
erties properly evaluated. Currently, the use of several tumorigenic cell lines is accepted for the
manufacturing of viral vaccines, upon risk-benefit evaluation. For example, Vero cells are still
used in Poliovirus vaccine production, although recent data showed growing evidence of
tumorigenicity acquisition during serial subcultivation [16–18].
The aim of this study was to characterize different simian cell lines and assess their suitabil-
ity for large-scale production. In particular, different aspects were investigated: microbiolog-
ical evaluation, species of origin, potential in vitro and in vivo tumorigenic evaluation and
Poliovirus amplification.
Microbiological results demonstrated the absence of viral and mycoplasma contamination
and the isoenzyme test confirmed the monkey origin for all the analyzed cell lines.
The most crucial point regarding in vitro and in vivo tumorigenic evaluation permitted to
express some interesting considerations.
Among the thrirteen cell lines investigated, only six (BS-C-1, CV-1, FRhK-4, CYNOM-K1,
4647, 4MBr-5) did not induce in vitro transformed colonies. Inconclusive findings were found
for MA-104 cell line, since its soft-agar colonies appeared to be morphologically different from
those observed in positive control.
Fig 3. Susceptibility of cell lines to Poliovirus. Attenuated Poliovirus Sabin LsC 2ab Sabin type 1 (Panel A), P712 Ch 2ab Sabin type 2 (B) and Leon
12alb Sabin type 3 (C) infectious titers obtained on the indicated cell lines. Data are reported as TCID50/ml log10 mean ± standard error of the mean.
Asterisk indicates a P value < 0.05 significance between the two data sets marked by the line.
doi:10.1371/journal.pone.0169391.g003
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Since the in vitro transformation results do not completely overlap with in vivo tumorige-
nicity ones, these cell lines were also injected into athymic mice, resulting free of any tumori-
genic characteristics. In particular, CYNOM-K1, FRhK-4, 4MBr-5, 4647 cell lines did not
show any evidence of macroscopic pathological tumors; necropsy was performed in order to
collect sample for histological analysis. The obtained outcomes demonstrated the absence of
pathological lesions either of neoplastic or inflammatory origin for all the selected cell lines.
BS-C-1 and CV-1 cell line were not assayed because already published data reported their
tumorigenic features [18–20]. Among the five tested cell lines, results of the in vivo tumorige-
nicity test confirmed the data obtained from the transformation assay performed through the
in vitro test and they both indicate no transformation features. The lack of previous studies
reporting in vivo investigation of the tested lines allows no comparison of the results.
FRhK-4, CYNOM-K1, 4647, 4MBr-5 cell lines allowed the growth of the three viral types of
attenuated Sabin Poliovirus as well as Vero and HeLa cells, with even superior performance in
the case of Leon 12alb Sabin type 3. Since they resulted not transformed, devoid of tumorige-
nicity and characterized by a good replication capacity, these cells may represent alternative
substrates for Poliovirus production to primary cell cultures from monkey kidneys, or other
potentially tumorigenic cell lines, as Vero [31]. However, the continuous growth of FRhK-4
and 4647 cells, compared to the finite CYNOM-K1 cell line and the EGF-dependent 4MBr-5
[32, 33], make these cell lines more indicated for a large-scale production. Finally, another
practical parameter to take in consideration is the in vitro growth of these cell lines. It was
noticed a different trend in the doubling time of each biological substrate. As described in liter-
ature [34], Vero cells grow in 24–48 hours until a 70%-80% of confluence that represents a cor-
rect percentage for viral amplification use. During the present study, FRhK-4 and 4647 cells, as
above mentioned, demonstrated a doubling time similar to Vero cells (48 hours) in compari-
son to CYNOM-K1 and 4MBr-5, that reach 70%-80% of confluence after 72 or more hours of
incubation.
These results outlined the importance of a deep and constant monitoring of biological sub-
strates, in order to highlight all potential risks related to the uncontrolled serial amplification.
Cell batches for biological manufacturing should be maintained at established in vitro passages
and properly tested according to the good laboratory practice and international guidelines.
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